{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:33:49Z","timestamp":1792794829660,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11033-020-06033-x","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T10:03:10Z","timestamp":1606903390000},"page":"9895-9912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Exploring the molecular approach of COX and LOX in Alzheimer\u2019s and Parkinson\u2019s disorder"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7874-0469","authenticated-orcid":false,"given":"Arun","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishnoor","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archit","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,2]]},"reference":[{"key":"6033_CR1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1046\/j.1532-5415.2002.50619.x","volume":"50","author":"CJ Wilson","year":"2002","unstructured":"Wilson CJ, Finch CE, Cohen HJ (2002) Cytokines and cognition\u2014the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 50:2041\u20132056","journal-title":"J Am Geriatr Soc"},{"key":"6033_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2016.09.003","volume":"114","author":"C Joffre","year":"2016","unstructured":"Joffre C, Gr\u00e9goire S, Smedt VE, Acar N, Bretillon L, Nadjar A, Lay\u00e9 S (2016) Modulation of brain PUFA content in different experimental models of mice. Prostaglandins Leukot Essent Fatty Acids 114:1\u201310","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"6033_CR3","doi-asserted-by":"publisher","unstructured":"Joffre C (2019) Polyunsaturated fatty acid metabolism in the brain and brain cells. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.88232","DOI":"10.5772\/intechopen.88232"},{"issue":"2","key":"6033_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI116245","volume":"91","author":"RI Sperling","year":"1993","unstructured":"Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR (1993) Dietary omega-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91(2):651\u2013660","journal-title":"J Clin Invest"},{"issue":"12","key":"6033_CR5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","volume":"15","author":"RP Bazinet","year":"2014","unstructured":"Bazinet RP, Lay\u00e9 S (2014) Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 15(12):771\u2013785","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"6033_CR6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","volume":"192","author":"CN Serhan","year":"2000","unstructured":"Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192(8):1197\u20131204","journal-title":"J Exp Med"},{"key":"6033_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbi.2018.07.025","volume":"76","author":"C Rey","year":"2019","unstructured":"Rey C, Delpech JC, Madore C, Nadjar A, Greenhalgh AD, Amadieu C, Aubert A, Pallet V, Vaysse C, Lay\u00e9 S, Joffre C (2019) Dietary n-3 long chain PUFA supplementation promotes a proresolvingoxylipin profile in the brain. Brain Behav Immun 76:17\u201327","journal-title":"Brain Behav Immun"},{"issue":"2","key":"6033_CR8","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s12035-017-0413-x","volume":"55","author":"SM Shalini","year":"2018","unstructured":"Shalini SM, Ho CFY, Ng YK, Tong JX, Ong ES, Herr DR, Dawe GS, Ong WY (2018) Distribution of Alox15 in the rat brain and its role in prefrontal cortical resolvin D1 formation and spatial working memory. Mol Neurobiol 55(2):1537\u20131550","journal-title":"Mol Neurobiol"},{"issue":"5","key":"6033_CR9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)63724-8","volume":"164","author":"D Pratico","year":"2004","unstructured":"Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA, Trojanowski JQ, Lee VMY (2004) 12\/15-lipoxygenase is increased in Alzheimer\u2019s disease: possible involvement in brain oxidative stress. Am J Pathol 164(5):1655\u20131662","journal-title":"Am J Pathol"},{"issue":"3","key":"6033_CR10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1194\/jlr.M053058","volume":"56","author":"L Sun","year":"2015","unstructured":"Sun L, Xu YW, Han J, Liang H, Wang N, Cheng Y (2015) 12\/15-Lipoxygenase metabolites of arachidonic acid activatePPARgamma: a possible neuroprotective effect in ischemic brain. J Lipid Res 56(3):502\u2013514","journal-title":"J Lipid Res"},{"issue":"10","key":"6033_CR11","doi-asserted-by":"crossref","first-page":"e26591","DOI":"10.1371\/journal.pone.0026591","volume":"6","author":"J Bystrom","year":"2011","unstructured":"Bystrom J, Wray JA, Sugden MC, Holness MJ, Swales KE, Warner TD, Edin ML, Zeldin DC, Gilroy DW, Bishop-Bailey D (2011) Endogenous epoxygenases are modulators of monocyte\/macrophage activity. PLoS One 6(10):e26591","journal-title":"PLoS One"},{"key":"6033_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1471-4159.2006.04371.x","volume":"101","author":"AA Farooqui","year":"2007","unstructured":"Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101:577\u2013599","journal-title":"J Neurochem"},{"key":"6033_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","volume":"106","author":"AA Farooqui","year":"2000","unstructured":"Farooqui AA, Horrocks LA, Farooqui T (2000b) Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 106:1\u201329","journal-title":"Chem Phys Lipids"},{"key":"6033_CR14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1989.tb22596.x","volume":"559","author":"AA Farooqui","year":"1989","unstructured":"Farooqui AA, Rammohan KW, Horrocks LA (1989) Isolation, characterization and regulation of diacylglycerol lipases from bovine brain. Ann N Y Acad Sci 559:25\u201336","journal-title":"Ann N Y Acad Sci"},{"key":"6033_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00109-003-0467-2","volume":"81","author":"VN Bochkov","year":"2003","unstructured":"Bochkov VN, Leitinger N (2003) Anti-inflammatory properties of lipid oxidation products. J Mol Med 81:613\u2013626","journal-title":"J Mol Med"},{"key":"6033_CR16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1471-4159.2004.02786.x","volume":"91","author":"H Lee","year":"2004","unstructured":"Lee H, Villacreses NE, Rapoport SI, Rosenberger TA (2004) In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J Neurochem 91:936\u2013945","journal-title":"J Neurochem"},{"key":"6033_CR17","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00001756-200210280-00026","volume":"13","author":"M Kolko","year":"2002","unstructured":"Kolko M, Rodriguez de Turco EB, Diemer NH, Bazan NG (2002) Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors. NeuroReport 13:1963\u20131966","journal-title":"NeuroReport"},{"key":"6033_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1194\/jlr.R300016-JLR200","volume":"45","author":"GY Sun","year":"2004","unstructured":"Sun GY, Xu J, Jensen MD, Simonyi A (2004b) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J Lipid Res 45:205\u2013213","journal-title":"J Lipid Res"},{"key":"6033_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-3-28","volume":"3","author":"GSD Moses","year":"2006","unstructured":"Moses GSD, Jensen MD, Lue LF, Walker DG, Sun AY, Simonyi A, Sun GY (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer\u2019s disease. J Neuroinflammation 3:28\u201338","journal-title":"J Neuroinflammation"},{"key":"6033_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","volume":"52","author":"JW Phillis","year":"2006","unstructured":"Phillis JW, Horrocks LA, Farooqui AA (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 52:201\u2013243","journal-title":"Brain Res Rev"},{"key":"6033_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1096\/fj.03-0837com","volume":"18","author":"DW Gilroy","year":"2004","unstructured":"Gilroy DW, Newson J, Sawmynaden PA, Willoughby DA, Croxtall JD (2004) A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J 18:489\u2013498","journal-title":"FASEB J"},{"key":"6033_CR22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1471-4159.2001.00080.x","volume":"76","author":"J Zhang","year":"2001","unstructured":"Zhang J, Rivest S (2001) Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem 76:855\u2013864","journal-title":"J Neurochem"},{"key":"6033_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2005.05.003","volume":"73","author":"N Chiang","year":"2005","unstructured":"Chiang N, Arita M, Serhan CN (2005) Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids 73:163\u2013177","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"6033_CR24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm1355","volume":"12","author":"FS Machado","year":"2006","unstructured":"Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J (2006) Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 12:330\u2013334","journal-title":"Nat Med"},{"key":"6033_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/154411130301400102","volume":"14","author":"A Kantarci","year":"2003","unstructured":"Kantarci A, Van Dyke TE (2003) Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 14:4\u201312","journal-title":"Crit Rev Oral Biol Med"},{"key":"6033_CR26","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/0929867033457115","volume":"10","author":"SS Fam","year":"2003","unstructured":"Fam SS, Morrow JD (2003) The isoprostanes: unique products of arachidonic acid oxidation\u2014a review. Curr Med Chem 10:1723\u20131740","journal-title":"Curr Med Chem"},{"key":"6033_CR27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s11745-004-1339-7","volume":"39","author":"CN Serhan","year":"2004","unstructured":"Serhan CN, Arita M, Hong S, Gotlinger K (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39:1125\u20131132","journal-title":"Lipids"},{"key":"6033_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.plefa.2005.05.009","volume":"73","author":"K Gronert","year":"2005","unstructured":"Gronert K (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot Essent Fatty Acids 73:221\u2013229","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"6033_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11064-015-1776-x","volume":"41","author":"GA Czapski","year":"2016","unstructured":"Czapski GA, Czubowicz K, Strosznajder JB, Strosznajder RP (2016) The lipoxygenases: their regulation and implication in Alzheimer\u2019s disease. Neurochem Res 41:243\u2013257. https:\/\/doi.org\/10.1007\/s11064-015-1776-x","journal-title":"Neurochem Res"},{"issue":"2","key":"6033_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo L, Wu JW, Uversky V (2012) \u0391-synuclein misfolding and Parkinson's disease. Biochim Biophys Acta 1822(2):261\u2013285","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"6033_CR31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.parkreldis.2011.11.003","volume":"18","author":"TG Ton","year":"2012","unstructured":"Ton TG, Jain S, Biggs ML, Thacker EL, Strotmeyer ES, Boudreau R, Newman AB, Longstreth WT Jr, Checkoway H (2012) Markers of inflammation in prevalent and incident Parkinson\u2019s disease in the Cardiovascular Health Study. Parkinsonism Relat Disord 18(3):274\u2013278","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"6033_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7827(97)00002-7","volume":"36","author":"S Yamamoto","year":"1997","unstructured":"Yamamoto S, Suzuki H, Ueda N (1997) Arachidonate 12-lipoxygenases. Prog Lipid Res 36(1):23\u201341","journal-title":"Prog Lipid Res"},{"issue":"2","key":"6033_CR33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","volume":"47","author":"G Schmitz","year":"2008","unstructured":"Schmitz G, Ecker J (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47(2):147\u2013155","journal-title":"Prog Lipid Res"},{"issue":"2\u20133","key":"6033_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(97)85419-2","volume":"326","author":"E Amandi-Burgermeister","year":"1997","unstructured":"Amandi-Burgermeister E, Tibes U, Kaiser BM, Friebe WG, Scheuer WV (1997) Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2. Eur J Pharmacol 326(2\u20133):237\u2013250","journal-title":"Eur J Pharmacol"},{"key":"6033_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0083-6729(08)60924-3","volume":"54","author":"HN Sorensen","year":"1998","unstructured":"Sorensen HN, Treuter E, Gustafsson JA (1998) Regulation of peroxisome proliferator-activated receptors. Vitam Horm 54:121\u2013166","journal-title":"Vitam Horm"},{"issue":"1","key":"6033_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.22-01-00257.2002","volume":"22","author":"AJ Hampson","year":"2002","unstructured":"Hampson AJ, Grimaldi M (2002) 12-Hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J Neurosci 22(1):257\u2013264","journal-title":"J Neurosci"},{"issue":"5","key":"6033_CR37","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)61224-2","volume":"167","author":"CM Chinnici","year":"2005","unstructured":"Chinnici CM, Yao Y, Ding T, Funk CD, Pratico D (2005) Absence of 12\/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice. Am J Pathol 167(5):1371\u20131377","journal-title":"Am J Pathol"},{"issue":"3\u20134","key":"6033_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.plefa.2007.08.007","volume":"77","author":"MP Zafiriou","year":"2007","unstructured":"Zafiriou MP, Deva R, Ciccoli R, Siafaka-Kapadai A, Nigam S (2007) Biological role of hepoxilins: upregulation of phospholipid hydroperoxide glutathione peroxidase as a cellular response to oxidative stress? Prostaglandins Leukot Essent Fatty Acids 77(3\u20134):209\u2013215","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"47","key":"6033_CR39","doi-asserted-by":"crossref","first-page":"10616","DOI":"10.1523\/JNEUROSCI.2469-04.2004","volume":"24","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Wang H, Li J, Jimenez DA, Levitan ES, Aizenman E, Rosenberg PA (2004) Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci 24(47):10616\u201310627","journal-title":"J Neurosci"},{"issue":"6","key":"6033_CR40","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/acel.12136","volume":"12","author":"PF Giannopoulos","year":"2013","unstructured":"Giannopoulos PF, Joshi YB, Chu J, Pratico D (2013) The 12-15-lipoxygenase is a modulator of Alzheimer\u2019s-related tau pathology in vivo. Aging Cell 12(6):1082\u20131090","journal-title":"Aging Cell"},{"issue":"5","key":"6033_CR41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-011-0412-7","volume":"36","author":"JB Strosznajder","year":"2011","unstructured":"Strosznajder JB, Cieslik M, Cakala M, Jesko H, Eckert A, Strosznajder RP (2011) Lipoxygenases and poly(ADP-ribose) polymerase in amyloid beta cytotoxicity. Neurochem Res 36(5):839\u2013848","journal-title":"Neurochem Res"},{"issue":"10","key":"6033_CR42","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/00001756-200107200-00031","volume":"12","author":"A Lebeau","year":"2001","unstructured":"Lebeau A, Esclaire F, Rostene W, Pelaprat D (2001) Baicalein protects cortical neurons from beta-amyloid (25\u201335) induced toxicity. NeuroReport 12(10):2199\u20132202","journal-title":"NeuroReport"},{"issue":"5","key":"6033_CR43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1474-4422(02)00133-3","volume":"1","author":"PS Aisen","year":"2002","unstructured":"Aisen PS (2002) The potential of anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease. Lancet Neurol 1(5):279\u2013284","journal-title":"Lancet Neurol"},{"issue":"Pt 6","key":"6033_CR44","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1042\/BST0341277","volume":"34","author":"WJ Lukiw","year":"2006","unstructured":"Lukiw WJ, Bazan NG (2006) Survival signalling in Alzheimer\u2019s disease. Biochem Soc Trans 34(Pt 6):1277\u20131282","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"6033_CR45","doi-asserted-by":"crossref","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer\u2019s disease models. PLoS One 6(1):e15816","journal-title":"PLoS One"},{"key":"6033_CR46","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/01.STR.0000249004.25444.a5","volume":"37","author":"K Van Leyen","year":"2006","unstructured":"Van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH (2006) Baicalein and 12\/15-lipoxygenase in the ischemic brain. Stroke 37:3014\u20133018","journal-title":"Stroke"},{"key":"6033_CR47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","volume":"19","author":"Y Li","year":"1997","unstructured":"Li Y, Maher P, Schubert DA (1997) Role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19:453\u2013463","journal-title":"Neuron"},{"key":"6033_CR48","doi-asserted-by":"crossref","first-page":"21542","DOI":"10.1074\/jbc.M213174200","volume":"278","author":"S Canals","year":"2003","unstructured":"Canals S, Casarejos MJ, De Bernardo S, Rodriguez-Martin E, Mena MA (2003) Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J Biol Chem 278:21542\u201321549","journal-title":"J Biol Chem"},{"issue":"7\u20138","key":"6033_CR49","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","volume":"38","author":"C Charlier","year":"2003","unstructured":"Charlier C, Michaux C (2003) Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 38(7\u20138):645\u2013659","journal-title":"Eur J Med Chem"},{"issue":"2","key":"6033_CR50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pnpbp.2010.07.032","volume":"35","author":"H Manev","year":"2011","unstructured":"Manev H et al (2011) Cyclooxygenases and 5-lipoxygenase in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 35(2):315\u2013319","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"6033_CR51","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","volume":"22","author":"O Firuzi","year":"2008","unstructured":"Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratic\u00f2 D (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer\u2019s disease. FASEB J 22(4):1169\u20131178","journal-title":"FASEB J"},{"issue":"21","key":"6033_CR52","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","volume":"92","author":"J Cl\u00e0ria","year":"1995","unstructured":"Cl\u00e0ria J, Serhan CN (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A 92(21):9475\u20139479","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5\u20136","key":"6033_CR53","first-page":"170","volume":"86","author":"LS Chu","year":"2010","unstructured":"Chu LS, Fang SH, Zhou Y, Yin YJ, Chen WY, Li JH, Sun J, Wang ML, Zhang WP, Wei EQ (2010) Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sci 86(5\u20136):170\u2013177","journal-title":"Life Sci"},{"key":"6033_CR54","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","volume":"93","author":"WE Kaufmann","year":"1996","unstructured":"Kaufmann WE, Worley PF, Pegg J, Bremer M, Isakson P (1996) COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc Natl Acad Sci U S A 93:2317\u20132321","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6033_CR55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"JR Vane","year":"1998","unstructured":"Vane JR, Bakhle YS, Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97\u2013120","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6033_CR56","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00001756-199703240-00020","volume":"8","author":"A Oka","year":"1997","unstructured":"Oka A, Takashima S (1997) Induction of cyclo-oxygenase 2 in brains of patients with Down\u2019s syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. Neuroreport 8:1161\u20131164","journal-title":"Neuroreport"},{"key":"6033_CR57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"6033_CR58","first-page":"487","volume":"58","author":"L Ho","year":"2001","unstructured":"Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS, Pasinetti GM (2001) Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol 58:487\u2013492","journal-title":"Arch Neurol"},{"key":"6033_CR59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nbd.2003.11.028","volume":"15","author":"JJ Hoozemans","year":"2004","unstructured":"Hoozemans JJ, Veerhuis R, Rozemuller AJ, Arendt T, Eikelenboom P (2004) Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex. Neurobiol Dis 15:492\u2013499","journal-title":"Neurobiol Dis"},{"key":"6033_CR60","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.17-10-03588.1997","volume":"17","author":"I Vincent","year":"1997","unstructured":"Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2\/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17:3588\u20133598","journal-title":"J Neurosci"},{"key":"6033_CR61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s004410100396","volume":"305","author":"DX Liu","year":"2001","unstructured":"Liu DX, Greene LA (2001) Neuronal apoptosis at the G1\/S cell cycle checkpoint. Cell Tissue Res 305:217\u2013228","journal-title":"Cell Tissue Res"},{"key":"6033_CR62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","volume":"26","author":"GK Gouras","year":"2005","unstructured":"Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer\u2019s disease. Neurobiol Aging 26:1235\u20131244","journal-title":"Neurobiol Aging"},{"key":"6033_CR63","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/138161208784480171","volume":"14","author":"JJM Hoozemans","year":"2008","unstructured":"Hoozemans JJM et al (2008) Cyclooxygenase-1 and -2 in the different stages of Alzheimer\u2019s disease pathology. Curr Pharm Des 14:1419\u20131427","journal-title":"Curr Pharm Des"},{"key":"6033_CR64","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-1033.1997.00726.x","volume":"243","author":"MK Bauer","year":"1997","unstructured":"Bauer MK, Lieb K, Schulze-Osthoff K, Berger M, Gebicke-Haerter PJ, Bauer J et al (1997) Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem 243:726\u2013731","journal-title":"Eur J Biochem"},{"issue":"2","key":"6033_CR65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/WAD.0b013e3181572046","volume":"22","author":"V Alvarez","year":"2008","unstructured":"Alvarez V, Gonz\u00e1lez P, Corao AI, Men\u00e9ndez M, Lahoz CH, Mart\u00ednez C, Calatayud M, Morales B, Coto E (2008) The Sp1\/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene promoter is not associated with late onset Alzheimer disease. Alzheimer Dis Assoc Disord 22(2):177\u2013180","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1\u20133","key":"6033_CR66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainresbull.2007.02.015","volume":"73","author":"S A\u00efd","year":"2007","unstructured":"A\u00efd S, Bosetti F (2007) Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. Brain Res Bull 73(1\u20133):108\u2013113","journal-title":"Brain Res Bull"},{"issue":"6","key":"6033_CR67","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000101957","volume":"23","author":"K Fujimi","year":"2007","unstructured":"Fujimi K, Noda K, Sasaki K, Wakisaka Y, Tanizaki Y, Iida M, Kiyohara Y, Kanba S, Iwaki T (2007) Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer\u2019s disease: the Hisayama Study. Dement Geriatr Cogn Disord 23(6):423\u2013431","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"6033_CR68","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1998.9981","volume":"254","author":"Y Kitamura","year":"1999","unstructured":"Kitamura Y, Shimohama S, Koike H, KakimuraJi Y et al (1999) Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains. Biochem Biophys Res Commun 254(3):582\u2013586","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"6033_CR69","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.05.001","volume":"141","author":"T Melnikova","year":"2006","unstructured":"Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141(3):1149\u20131162","journal-title":"Neuroscience"},{"issue":"1","key":"6033_CR70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/156802608783334042","volume":"8","author":"T Kukar","year":"2008","unstructured":"Kukar T, Golde TE (2008) Possible mechanisms of action of NSAIDs and related compounds that modulate gamma-secretase cleavage. Curr Top Med Chem 8(1):47\u201353","journal-title":"Curr Top Med Chem"},{"key":"6033_CR71","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0306-4522(99)00455-8","volume":"95","author":"B Mirza","year":"2009","unstructured":"Mirza B, Hadberg H, Thomsen P, Moos T (2009) The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson\u2019s disease. Neuroscience 95:425\u2013432","journal-title":"Neuroscience"},{"key":"6033_CR72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/MN:29:2:197","volume":"29","author":"R De Simone","year":"2004","unstructured":"De Simone R, Ajmone-Cat MA, Minghetti L (2004) Atypical antiinflammatory activation of microglia induced by apoptotic neurons: possible role of phosphatidylserine-phosphatidylserine receptor interaction. Mol Neurobiol 29:197\u2013212","journal-title":"Mol Neurobiol"},{"key":"6033_CR73","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/89490","volume":"4","author":"P Bezzi","year":"2001","unstructured":"Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702\u2013710","journal-title":"Nat Neurosci"},{"key":"6033_CR74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","volume":"114","author":"TG Beach","year":"2007","unstructured":"Beach TG, Sue LI, Walker DG, Lue LF, Connor DJ, Caviness JN, Sabbagh MN, Adler CH (2007) Marked microglial reaction in normal aging human substantianigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol 114:419\u2013424","journal-title":"Acta Neuropathol"},{"key":"6033_CR75","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL Mcgeer","year":"1998","unstructured":"Mcgeer PL, Itagaki S, Boyes BE, Mcgeer EG (1998) Reactive microglia are positive for Hla-Dr in the SubstantiaNigra of Parkinsons and Alzheimers-disease brains. Neurology 38:1285\u20131291","journal-title":"Neurology"},{"key":"6033_CR76","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Leenders KL (2010) Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol 8:62\u201368","journal-title":"Curr Neuropharmacol"},{"key":"6033_CR77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","volume":"18","author":"P Teismann","year":"2003","unstructured":"Teismann P, Tieu K, Cohen O, Choi DK, Wu DC, Marks D, Vila M, Jackson-Lewis V, Przedborski S (2003) Pathogenic role of glial cells in Parkinson\u2019s disease. Mov Disord 18:121\u2013129","journal-title":"Mov Disord"},{"key":"6033_CR78","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","volume":"88","author":"T Dehmer","year":"2004","unstructured":"Dehmer T (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494\u2013501","journal-title":"J Neurochem"},{"key":"6033_CR79","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901\u2013910","journal-title":"J Neuropathol Exp Neurol"},{"key":"6033_CR80","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","volume":"16","author":"C Knott","year":"2000","unstructured":"Knott C, Stern G, Wilkin GP (2000) Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16:724\u2013739","journal-title":"Mol Cell Neurosci"},{"key":"6033_CR81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-1-6","volume":"1","author":"R Sanchez-Pernaute","year":"2004","unstructured":"Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease. J Neuroinflammation 1:6","journal-title":"J Neuroinflammation"},{"key":"6033_CR82","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O'Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96:706\u2013718","journal-title":"J Neurochem"},{"key":"6033_CR83","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","volume":"100","author":"RL Hunter","year":"2007","unstructured":"Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100:1375\u20131386","journal-title":"J Neurochem"},{"key":"6033_CR84","first-page":"134","volume":"19","author":"TG Wang","year":"2005","unstructured":"Wang TG, Pei Z, Zhang W, Liu B, Langenbach R, Lee C, Wilson B, Reece JM, Miller DS, Hong JS (2005) MPP+- induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J 19:134\u20131136","journal-title":"FASEB J"},{"key":"6033_CR85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","volume":"115","author":"AL Bartels","year":"2008","unstructured":"Bartels AL, Willemsen ATM, Kortekaas R, de Jong BM, de Vries R, de Klerk O, van Oostrom JCH, Portman A, Leenders KL (2008) Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson\u2019s disease, PSP and MSA. J Neural Transm 115:1001\u20131009","journal-title":"J Neural Transm"},{"key":"6033_CR86","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","volume":"73","author":"B Bauer","year":"2008","unstructured":"Bauer B, Anika MSH, Pekcec A, Toellner K, Miller DSPH (2008) Seizure-induced up-regulation of P glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Mol Pharmacol 73:1444\u20131453","journal-title":"Mol Pharmacol"},{"key":"6033_CR87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nucmedbio.2008.01.005","volume":"35","author":"EFJ De Vries","year":"2008","unstructured":"De Vries EFJ, Doorduin J, Vellinga NAR, Waarde AV (2008) Can celecoxib affect Pglycoprotein-mediated drug efflux? A microPET study. Nucl Med Biol 35:459\u2013466","journal-title":"Nucl Med Biol"},{"key":"6033_CR88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.brainresrev.2004.12.015","volume":"48","author":"L Minghetti","year":"2005","unstructured":"Minghetti L, Ajmone-Cat MA, De Berardinis MA, De Simone R (2005) Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res Rev 48:251\u2013256","journal-title":"Brain Res Rev"},{"key":"6033_CR89","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.4485-03.2004","volume":"24","author":"L McCullough","year":"2004","unstructured":"McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24:257\u2013268","journal-title":"J Neurosci"},{"key":"6033_CR90","first-page":"1","volume":"15","author":"PR Colville-Nash","year":"2001","unstructured":"Colville-Nash PR, Gilroy DW (2001) Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammation. Bio Drugs 15:1\u20139","journal-title":"Bio Drugs"},{"key":"6033_CR91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-5-17","volume":"5","author":"S Aid","year":"2008","unstructured":"Aid S, Langenbach R, Bosetti F (2008) Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. J Neuroinflammation 5:17","journal-title":"J Neuroinflammation"},{"key":"6033_CR92","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol 58:963\u2013967","journal-title":"Ann Neurol"},{"key":"6033_CR93","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","volume":"69","author":"AD Wahner","year":"2007","unstructured":"Wahner AD, Bronstein JM, Bordelon YM, Ritz B (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology 69:1836\u20131842","journal-title":"Neurology"},{"key":"6033_CR94","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/01.wnl.0000227906.99570.cc","volume":"67","author":"JH Bower","year":"2006","unstructured":"Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA (2006) Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 67:494\u2013496","journal-title":"Neurology"},{"key":"6033_CR95","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.20856","volume":"21","author":"TG Ton","year":"2006","unstructured":"Ton TG, Heckbert SR, Longstreth WT Jr, Rossing MA, Kukull WA, Franklin GM, Swanson PD, Smith-Weller T, Checkoway H (2006) Nonsteroidal anti-inflammatory drugs and risk of Parkinson\u2019s disease. Mov Disord 21:964\u2013969","journal-title":"Mov Disord"},{"key":"6033_CR96","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jocn.2007.02.095","volume":"15","author":"M Etminan","year":"2008","unstructured":"Etminan M, Carleton BC, Samii A (2008) Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study. J Clin Neurosci 15:576\u2013577","journal-title":"J Clin Neurosci"},{"issue":"2","key":"6033_CR97","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12017-015-8351-0","volume":"17","author":"L Minutoli","year":"2015","unstructured":"Minutoli L, Marini H, Rinaldi M, Bitto A, Irrera N, Pizzino G, Pallio G, Cal\u00f2 M, Adamo EB, Trichilo V, Interdonato M, Galfo F, Squadrito F, Altavilla D (2015) A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury. Neuromolecular Med 17(2):192\u2013201","journal-title":"Neuromolecular Med"},{"issue":"5","key":"6033_CR98","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00011-017-1022-x","volume":"66","author":"A Bitto","year":"2017","unstructured":"Bitto A, Giuliani D, Pallio G, Irrera N, Vandini E, Canalini F, Zaffe D, Ottani A, Minutoli L, Rinaldi M, Guarini S, Squadrito F, Altavilla D (2017) Effects of COX1-2\/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice. Inflamm Res 66(5):389\u2013398","journal-title":"Inflamm Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-020-06033-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06033-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T05:40:04Z","timestamp":1607406004000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-020-06033-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":98,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6033"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06033-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}